dc.contributor.author |
Shakak, Amany Osman |
|
dc.contributor.author |
Supervisor,- Humodi Ahmed Saeed |
|
dc.date.accessioned |
2014-03-11T06:46:27Z |
|
dc.date.available |
2014-03-11T06:46:27Z |
|
dc.date.issued |
2006-02-01 |
|
dc.identifier.citation |
Shakak,Amany Osman.IN VITRO ACTIVITY OF AMPICILLIN AGAINST BETA LACTAMASE PRODUCERS/Amany Osman Shakak;Humodi Ahmed Saeed.-Khartoum:Sudan University of Science and Technology,college of Medical Laboratory Science,2006.-68p. : ill. ; 28cm.-M.Sc. |
en_US |
dc.identifier.uri |
http://repository.sustech.edu/handle/123456789/3857 |
|
dc.description |
Thesis |
en_US |
dc.description.abstract |
This study was carried out in Khartoum State, during August to October
2005. The study was designed to evaluate in vitro activity of ampicillin
against β-lactamase producers.
Two hundred clinical specimens were collected. 38.5% of the specimens
were ear swabs, 36.5% wound swabs, and 25% urine.
Cultivation of these specimens on enriched and / or differential media
yielded isolation of 189 isolates.
β-Lactamase producers were detected by β-lactamase acidimetric
method.
Result showed that positive isolates were S.aureus (31.9%), E.coli
(21.6%), Ps. aeruginosa (16.4%), K. pneumoniae (15.5%), P.mirabilis
(13.7%) and P. vulgaris (0.9%).
Ampicillin activity against β-lactamase determined by using National
Committee for Clinical Laboratory Standards (NCCLS) modified Kirby-
Bauer Disc Diffusion technique. The result revealed that only 8.6% of the
β-lactamase producers were sensitive to ampicillin while 91.4% were
resist the action of ampicillin. |
en_US |
dc.description.sponsorship |
Sudan University of Science and Technology |
en_US |
dc.language.iso |
en |
en_US |
dc.publisher |
Sudan University of Science and Technology |
en_US |
dc.subject |
Drugs-Effective |
en_US |
dc.subject |
activity-ampicillin-against β-lactamase |
en_US |
dc.title |
IN VITRO ACTIVITY OF AMPICILLIN AGAINST BETA LACTAMASE PRODUCERS |
en_US |
dc.type |
Thesis |
en_US |